Send feedback

ADGRE2 p.Pro399=

c.1197T>G · rs140888899 · VCV714764

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
rare (popmax 0.968%, afr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.68GERP -3.1, phastCons 0.017
Overall
CADD1.155PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.968% African / African-American · 726/75,030 alleles
Filtering AF 0.909% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.886%
Overall 0.0511% 824/1,613,428 alleles · rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.968% 103
Remaining individualsnot grpmax-eligible 0.056% 1,784
Admixed American 0.0534% 1,874
Middle Eastern 0.0517% 1,935
European (non-Finnish) 0.00237% 42,133

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ADGRE2
Protein
p.Pro399=
Coding
c.1197T>G
MANE Select
NM_013447
dbSNP
rs140888899
Type
single nucleotide variant
Location
chr19:14755873 (GRCh38)
Gene constraint
LOEUF 1.028 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.44 · 3 PDB
Residue 399
the gain-b domain
Full ADGRE2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/adgre2-p-pro399 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown